✨#CHIRONProject's secondee Micheál Ó Dálaigh's secondment experience (GALWAY to UBERN):

"My month-long secondment with my lab mate Jacopo Umberto Verga to the Krebs group, led by Philippe Krebs, at the Institute of Tissue Medicine and Pathology at the University of Bern was a worthwhile experience.

For #CHIRONProject's second annual meeting, team members gathered in beautiful Budapest (Hungary). In this productive and engaging week, we had the opportunity to discuss the project's results, coordinate the next steps, and have a scientific and personal exchange.

This study illustrates the relevance of #CHIRONProject’s goal to identify cancer types that can be treated via death receptors. CHIRON also develops novel DR-based anti-tumor therapies, which include the development of antibody-drug conjugates (ADC), spearheaded by the consortium partner COVALAB.

Our partner, Dr. Philippe Krebs from the University of Bern (Switzerland), arrived at e-NIOS (Athens, Greece) to advance #CHIRONProject's collaboration with our partners, Dr. Aristotelis Chatziioannou and Dr. Eleftherios Pilalis, and the rest of the team.
We are excited about the progress ahead🌟